Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Otsuka Holdings Co., Ltd. (OTSKY) (OTSKY)
:OTSKY
Holding OTSKY?
Track your performance easily
OTSKY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$17.79 - $31.16
Previous CloseN/A
Volume11.00K
Average Volume (3M)38.82K
Market Cap
$27.48B
Enterprise Value$29.70B
Total Cash (Recent Filing)$579.16B
Total Debt (Recent Filing)$193.97B
Price to Earnings (P/E)27.7
Beta0.55
Next Earnings
Feb 14, 2025EPS Estimate
0.25Last Dividend Ex-Date
Dec 28, 2023Dividend Yield1.83%
Share Statistics
EPS (TTM)0.93
Shares Outstanding1,104,049,400
10 Day Avg. Volume44,429
30 Day Avg. Volume38,823
Standard Deviation0.07
R-Squared0.07
Alpha0.00330
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.40
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue0.02
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Otsuka Holdings Co News
PremiumCompany Announcements
Otsuka Holdings Reports Strong Nine-Month Earnings Growth
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.33% Other Institutional Investors
99.67% Public Companies and
Individual Investors
OTSKY FAQ
What was Otsuka Holdings Co., Ltd. (OTSKY)’s price range in the past 12 months?
Otsuka Holdings Co., Ltd. (OTSKY) lowest stock price was $17.79 and its highest was $31.16 in the past 12 months.
What is Otsuka Holdings Co., Ltd. (OTSKY)’s market cap?
Otsuka Holdings Co., Ltd. (OTSKY)’s market cap is $27.48B.
When is Otsuka Holdings Co., Ltd. (OTSKY)’s upcoming earnings report date?
Otsuka Holdings Co., Ltd. (OTSKY)’s upcoming earnings report date is Feb 14, 2025 which is in 26 days.
How were Otsuka Holdings Co., Ltd. (OTSKY)’s earnings last quarter?
Otsuka Holdings Co., Ltd. (OTSKY) released its earnings results on Oct 31, 2024. The company reported $0.508 earnings per share for the quarter, missing the consensus estimate of $0.628 by -$0.12.
Is Otsuka Holdings Co., Ltd. (OTSKY) overvalued?
According to Wall Street analysts Otsuka Holdings Co., Ltd. (OTSKY)’s price is currently Overvalued.
Does Otsuka Holdings Co., Ltd. (OTSKY) pay dividends?
Otsuka Holdings Co., Ltd. (OTSKY) pays a Semiannually dividend of $0.152 which represents an annual dividend yield of 1.83%. See more information on Otsuka Holdings Co., Ltd. (OTSKY) dividends here
What is Otsuka Holdings Co., Ltd. (OTSKY)’s EPS estimate?
Otsuka Holdings Co., Ltd. (OTSKY)’s EPS estimate is 0.25.
How many shares outstanding does Otsuka Holdings Co., Ltd. (OTSKY) have?
Otsuka Holdings Co., Ltd. (OTSKY) has 1,104,049,400 shares outstanding.
What happened to Otsuka Holdings Co., Ltd. (OTSKY)’s price movement after its last earnings report?
Otsuka Holdings Co., Ltd. (OTSKY) reported an EPS of $0.508 in its last earnings report, missing expectations of $0.628. Following the earnings report the stock price went up 1.806%.
Which hedge fund is a major shareholder of Otsuka Holdings Co., Ltd. (OTSKY)?
Currently, no hedge funds are holding shares in OTSKY
---
Otsuka Holdings Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.34%
12-Months-Change
Fundamentals
Return on Equity
5.89%
Trailing 12-Months
Asset Growth
9.81%
Trailing 12-Months
Company Description
Otsuka Holdings Co., Ltd. (OTSKY)
Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.
---
Technical Analysis
Takeda Pharmaceutical Company
―
Sanofi
―
Novartis
―
Eli Lilly & Co
―
Bayer
―
GlaxoSmithKline
―
---